Adaptol´s effect on lipid metabolism in patients with exertional angina of the I-III functional classes

Kozhokova L.Z.; Mkrtchyan V.R.

doi:https://doi.org/

Kozhokova L.Z.

Kafedra klinicheskoĭ farmakologii i terapii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Mkrtchyan V.R.

Z.P. Solovyov Research and Practical Psychoneurology Center, Moscow Healthcare Department, Moscow, Russia

Adaptol´s effect on lipid metabolism in patients with exertional angina of the I-III functional classes

Authors:

Kozhokova L.Z., Mkrtchyan V.R.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(1): 33‑37

Read: 7114 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kozhokova LZ, Mkrtchyan VR. Adaptol´s effect on lipid metabolism in patients with exertional angina of the I-III functional classes. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(1):33‑37. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

References:

Burchinskij S.G. Farmakoterapevticheskie aspekty primeneniya preparata "Аdaptol" [Pharmacological aspects of the drug "Adaptol"]. Liki (Kiev) 2004; 5: 6.
Gromov L., Dudko E. "Tipichnye" i "Аtipichnye" trankvilizatory [Typical "and" atypical "tranquilizers] Vestn farmakol i farmatsii 2003; 10: 11-17.
Zimakova I.E. Farmakologicheskie ehffekty novogo psikhotropnogo sredstva mebikara [Pharmacological effects of new psychotropic drug "Mebicar"]. Farmakol i toksikol 1977; 6:634-637.
Zimakova I.E., Karpov А.M., Tagirova T.S. i dr. Аnaliz raznoobraziya ehffektov trankvilizatora mebikara v ehksperimental'noj i klinicheskoj meditsine [Analysis of the effects of the tranquilizer "Mebicar" in experimental and clinical medicine]. Klin i teor med 1995; 85-87.
Zimakova I.E., Rudenko G.M., Karpov А.M. Primenenie mebikara v klinicheskoj praktike [Application of "Mebicar" in clinical practice] Metodicheskie rekomendatsii. 1989; 23.
Zimakova I.E., KHaziakhmetova V.N. Dnevnoj trankvilizator Mebikar dlya profilaktiki ishemicheskoj bolezni serdtsa [Daily tranquilizer "Mebicar" for prevention of coronary heart disease] Kazan med zhurn 1995; 2: 85-87.
Lapshina L.А., Kravchun P.G., SHevchenko O.S. Korrektsiya adaptolom psikhopatologicheskikh proyavlenij i oksidativnogo stressa u bol'nykh, perenesshikh infarkt miokarda [Correction by "Adaptol" of psychopathological manifestations and oxidative stress in patients with myocardial infarction] Vrach prakt 2008; 1: 23-30.
Maksareva E.YU., Kudryashova V.А., Zavizion V.А., KHurgin YU.I. KVCH-podobnoe dejstvie mocheviny i mebikara [EHF-like action of urea and "Mebicar"]. Rossijskij simpozium s mezhdunarodnym uchastiem "Millimetrovye volny v meditsine i biologii", 10-j: Materialy. 218-219
Salikhova R.R. Gipolipidemicheskie ehffekty trankvilizatora mebikara [Lipid effects of tranquilizer "Mebicar"]: Аvtoref. dis. ... kand. med. nauk. Kazan' 1996.
Statsenko M.E., Sporova O.E., SHilina N.N. i dr. Terapevticheskie vozmozhnosti adaptola v rannem postinfarktnom periode u bol'nykh s trevozhnymi rasstrojstvami [Therapeutic possibilities of "Adaptol" in the early postinfarction period in patients with anxiety disorders]. Kardiologiya i serdechno-sosud khir 2011; 4: 41-47.